# Intravenous Branched Chain Amino Acids for Hepatic Encephalopathy in ACLF

> **NCT04238416** · PHASE1 · COMPLETED · sponsor: **Post Graduate Institute of Medical Education and Research, Chandigarh** · enrollment: 70 (actual)

## Conditions studied

- Hepatic Encephalopathy
- Acute-On-Chronic Liver Failure

## Interventions

- **DRUG:** Branched chain amino acid
- **DRUG:** Lactulose

## Key facts

- **NCT ID:** NCT04238416
- **Lead sponsor:** Post Graduate Institute of Medical Education and Research, Chandigarh
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-01
- **Primary completion:** 2021-12-30
- **Final completion:** 2021-12-30
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2022-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04238416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04238416, "Intravenous Branched Chain Amino Acids for Hepatic Encephalopathy in ACLF". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT04238416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*